Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/SUVEN stock hub

NSE/SUVEN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/SUVENis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

59.1B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/SUVEN

In the news

Latest news · NSE/SUVEN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/En/a

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC-1,188.9

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/SUVEN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

152

Groups with data

Currency

INR

Showing 152 of 152 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	138
Employees Change	-3%
Employees Change Percent	-2.13
Enterprise value	INR 56.5B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE495B01020
Last refreshed	2026-05-10
Market cap	INR 59.1B
Price	INR 223
Price currency	INR
Rev Per Employee	511,710.14x
Sector	Healthcare
Sic	2833
Symbol	nse/SUVEN
Website	https://www.suven.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.65%
EV Earnings	-20.58x
P/B ratio	21.02x
P/S ratio	837.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	89.36%
Gross Profit	INR 63.1M
Gross Profit Growth	-6.51%
Gross Profit Growth Q	74.46%
Gross Profit Growth3 Y	-21.05%
Gross Profit Growth5 Y	-21.26%
Net Income	INR -2.7B
Net Income Growth Years	0%
Pretax Margin	-3,889.96%
Profit Per Employee	INR -19.9M
Roa5y	-41.87
Roe5y	-68.85
ROIC	-1,188.9
Roic5y	-201.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.6%
Cagr15y	18.99%
Cagr1y	62.04%
Cagr20y	6.19%
Cagr3y	55.86%
Cagr5y	19.4%
Div CAGR10	19.62%
Div CAGR3	-16.75%
Div CAGR5	-9.71%
EPS Growth Years	0
Revenue Growth	-6.77x
Revenue Growth Q	74.46x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-22.64x
Revenue Growth5 Y	-19.49x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 2.6B
Equity	INR 2.8B
Net Cash	INR 2.6B
Net Cash By Market Cap	INR 4.36
Net Cash Growth	54.9%
Net Debt Equity	INR -0.92
Tangible Book Value	INR 2.8B
Tangible Book Value Per Share	INR 12.65
WACC	8.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.12%
Dividend per share	INR 0
Last Dividend	INR 1.5

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	17.17%
1Y total return	61.98%
200-day SMA	189.4
3Y total return	278.71%
50-day SMA	168.1
50-day SMA vs 200-day SMA	50under200
5Y total return	142.59%
All Time High	645
All Time High Change	-65.45%
All Time High Date	2004-01-15
All Time Low	9.5
All Time Low Change	2,246%
All Time Low Date	2009-03-16
ATR	10.79
Beta	0.71
Ch YTD	34.04
High	226.3
High52	300
High52 Date	2025-07-15
High52ch	-25.71%
Low	217.8
Low52	124.1
Low52 Date	2026-03-24
Low52ch	79.89%
Ma50ch	32.56%
Price vs 200-day SMA	17.65%
RSI	70.88
RSI Monthly	61.2
RSI Weekly	67.68
Sharpe ratio	1.28x
Sortino ratio	2.37
Total Return	-2.12%
Tr YTD	34.04
Tr15y	1,257.53%
Tr1m	33.56%
Tr1w	4.92%
Tr3m	39.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR -2.8B
Operating margin	-4,002.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	74,998,483%
Shares Insiders	1.88%
Shares Institutions	2.94%
Shares Qo Q	0.83%
Shares Yo Y	2.12%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	575,305.1x
Bv Per Share	12.66
Ch10y	5.9
Ch15y	1,040
Ch1m	33.56
Ch1w	4.92
Ch1y	61.98
Ch20y	166.9
Ch3m	39.02
Ch3y	278.7
Ch5y	123.5
Ch6m	17.5
Change	1.12%
Change From Open	2.35
Close	220.4
Days Gap	-1.2
Depreciation Amortization	48,941,000
Dollar Volume	85,742,100.7
Earnings Date	2026-05-13
EBIT	INR -2.8B
EBITDA	INR -2.8B
EPS	INR -12.35
F Score	1
Fiscal Year End	March
Founded	1,989
Is Primary Listing	0
Last Earnings Date	2026-01-29
Last Report Date	2025-12-31
Ma150	171.4
Ma150ch	30.02%
Ma20	206.3
Ma20ch	8.04%
Next Earnings Date	2026-05-13
Open	217.8
Position In Range	60.19
Price Date	2026-05-08
Ptbv Ratio	21.03
Relative Volume	0.67x
Revenue	70,616,000x
Tr20y	232.09%
Tr6m	17.5%
Volume	384,718

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/SUVEN pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/SUVEN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/SUVEN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.9%

Share of float held by funds and institutions

Insider ownership

+1.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.1%

Negative means the company is buying back shares.

Technical

NSE/SUVEN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

70.9

Above 70: short-term overbought

Price vs 200-day MA

+17.6%

50/200-day relationship not available

Beta (5Y)

0.70

Less volatile than the market

Sharpe ratio

1.28

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/SUVEN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/SUVEN stock rating?

nse/SUVEN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/SUVEN analysis?

The full report lives at /stocks/nse/SUVEN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/SUVEN?

The latest report frames nse/SUVEN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/SUVEN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.